Benjamin Hohl
Chief Financial Officer at Enliven Therapeutics · 32 reported transactions in 1 company · latest trade Oct 19, 2026
Their trades
Sold | Oct 19, 2026 | Oct 19, 2026 close $38.70 → Oct 29, 2026 close $45.08. S&P 500 +0.8% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $59.53 → Oct 29, 2026 close $45.08. S&P 500 −0.1% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $59.53 → Oct 29, 2026 close $45.08. S&P 500 −0.1% over the same days. | ||
Sold | Jul 17, 2026 | Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days. | ||
Sold | Jul 17, 2026 | Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days. | ||
Sold | Jul 17, 2026 | Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days. | ||
Sold | Jul 17, 2026 | Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days. | ||
Sold | Jul 17, 2026 | Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days. |
$231.5K
Oct 19, 2026 close $38.70 → Oct 29, 2026 close $45.08. S&P 500 +0.8% over the same days.
$82.4K
Aug 17, 2026 close $59.53 → Oct 29, 2026 close $45.08. S&P 500 −0.1% over the same days.
$270.2K
Aug 17, 2026 close $59.53 → Oct 29, 2026 close $45.08. S&P 500 −0.1% over the same days.
$6.6K
Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days.
$140.8K
Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days.
$134.1K
Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days.
$19K
Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days.
$16.2K
Jul 17, 2026 close $53.20 → Oct 29, 2026 close $45.08. S&P 500 +3.9% over the same days.